Please assess the completion status of the following clinical trial:

Trial Title: Coronary MDCTA With Iopamidol Injection 370

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Provide informed consent~* At least 30 years of age~* Weight less than 250 lbs~* Known or suspected coronary artery disease and suspected to have significant coronary artery stenosis~* Undergo MDCTA scan~* Undergo coronary angiography within 2 weeks of MDCTA scan~Exclusion Criteria:~* Hx of hypersensitivity to iodinated contrast agents~* Known or suspected hyperthyroidism or pheochromocytoma~* Renal impairment~* History of coronary artery stent placement or bypass grafts~* Unstable~* Pregnant or lactating

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Isovue 370, 70 mL (Type: EXPERIMENTAL): iopamidol injection 370, 70 mL
- Isovue 370, 80 mL (Type: EXPERIMENTAL): iopamidol injection 370, 80 mL
- Isovue 370, 90 mL (Type: EXPERIMENTAL): iopamidol injection 370, 90 mL

Based on this trial design, predict the completion outcome and termination type (if applicable).